Enhertu
| Enhertu | |
|---|---|
| Term | Enhertu |
| Short definition | Enhertu (de-HER-also) A drug used to treat adults with certain types of HER2-positive or HER2-low breast cancer, HER2-positive gastric cancer, or cancer of the gastroesophageal junction or non-small cell Lung cancer that has a specific mutation in the HER2 gene. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Enhertu - (pronounced) (de-HER-also) A drug used to treat adults with certain types of HER2-positive or HER2-low breast cancer, HER2-positive gastric cancer, or cancer of the gastroesophageal junction or non-small cell Lung cancer that has a specific mutation in the HER2 gene. It is also being studied in the treatment of other types of cancer. Enhertu contains a monoclonal antibody called trastuzumab that attaches to a protein called HER2, which is found on some cancer cells. It also contains a cancer drug called deruxtecan, which can help kill cancer cells. Enhertu is a type of antibody-drug conjugate. Also called fam trastuzumab deruxtecan and trastuzumab deruxtecan
External links
- Medical encyclopedia article on Enhertu
- Wikipedia's article - Enhertu
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski